… (PTA) for long SFA lesions remains poor [3, 4]. Primary stent placement in long SFA lesions
has shown promising … However, in bare-metal stents (BMS) the risk of in-stent restenosis and …

… In real-world daily practice of endovascular therapy (EVT) for femoropopliteal lesions, we
have adopted 3 different approaches to stenting: BNS without cilostazol, BNS with cilostazol, …

… long SFA lesions (up tol4 cm) suitable for stenting … the bare metal stent group, being 22.9%
versus 21.1% respectively. The TLR was 6% in the sirolimus group and 13% in the bare Stent …

… The effect of antiplatelet therapy on PTA and stenting of SFA lesions needs to be properly …
of new SFA stents. As only subgroups of participants may benefit from stenting, trials should be …

… A total of 38 de novo SFA lesions from 32 patients were analyzed in this study. BMS were …
Outcomes associated with drug-eluting and bare-metal stents: A collaborative network meta-…

… artery (CIA) and superficial femoral artery (SFA) lesions, are scarce. We aimed to assess
the long-term outcomes after bare metal stenting by comparing CIA lesions with SFA lesions. …

… the impact of nitinol stenting of SFA lesions with a maximum … The ongoing VIBRANT (Viabahn
Versus Bare Nitinol Stent) … Viabahn endoprosthesis compared with bare metal stents. …

… However, few current studies have conducted direct real-world comparisons between primary
DESs and bare-metal stents (BMSs) for SFA occlusive disease. Therefore, we conducted …

… lesions were randomly assigned 1:1 to undergo either PEB followed by nitinol bare-metal
stent … group, includes not only stent body lesions, but also stent edge lesions; and class III is …

… midterm outcomes of polytetrafluoroethylene-covered stents (CSs) vs bare-metal stents (BMSs)
in the … of Peripheral Arterial Disease (TASC II) C and D iliac artery obstructive lesions. …